Interaction between motor fatigue and cognitive functioning in patients with multiple sclerosis

Interaction between motor fatigue and cognitive functioning in patients with multiple sclerosis - Motor fatigue and cognitive performance in MS patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON38018

Enrollment

Registered

2010-06-23

Start date

2011-05-13

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple sclerosis

Interventions

Fatigue task

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Relapsing-remitting multiple sclerosis EDSS

Exclusion criteria

Exclusion criteria: Psychiatric disorder Depression Neurological disorder other than MS EDSS >= 5,5 Hearing disorder Medication that influences (subjective) fatigue or force production (Amantadine, Amytryptiline, Pemoline, Tizanidine, Baclofen, Benzodiazepines, Potassium channel blockers, or modafinil. Or use of prednisolon in the past 6 weeks).

Design outcomes

Primary

Measure	Time frame
The primary parameters are the number of accurate responses to the CRT and the reaction times of these reactions.	—

Secondary

Measure	Time frame
Maximal voluntary contraction (MVC), decrease in force during fatigue.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)